IP Library Granted Patent US 12,186,549
Granted Patent B2
US 12,186,549 · App. 17/991,808 · Granted Jan 7, 2025

Subcutaneous device for monitoring and/or providing therapies

Inventor: Yatheendhar D. Manicka (Woodbury, MN)
Assignee: Manicka Institute LLC
A61N1/0504A61N1/059A61N1/37512A61N1/0563A61N1/368A61N1/37518
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,186,549
App. No.
17/991,808
Granted
Jan 7, 2025
Kind
B2
Abstract

A subcutaneously implantable device includes a housing, a clip attached to a top side of the housing, a first prong with a proximal end attached to the housing and a distal end extending away from the housing, and a first electrode on the first prong. The clip is configured to anchor the device to a muscle, a bone, and/or a tissue. The first prong is configured to contact a heart. The first electrode is configured to contact the heart. Sensing circuitry in the housing that is configured to sense an electrical signal from the heart, and therapeutic circuitry in the housing is in electrical communication with the first electrode and is configured to deliver electrical stimulation to the heart through the first electrode.

Claims (40)

1. A subcutaneously implantable device comprising:

a housing;

a clip attached to a top side of the housing that is configured to anchor the device to a muscle, a bone, and/or a first tissue, wherein the clip includes a top portion that is configured to be positioned on a first side of the muscle, the bone, and/or the first tissue and the housing is configured to be positioned on a second side of the muscle, the bone, and/or the first tissue;

a drug pump and a drug reservoir in the housing, wherein the drug pump is fluidly connected to the drug reservoir;

a first prong with a lumen extending through the first prong and having a proximal end attached to the housing and the drug pump, and a distal end extending away from the housing that is configured to contact an organ, a nerve, and/or a second tissue, wherein the first prong is fluidly connected to the drug pump; and

circuitry in the housing in electrical communication with the drug pump that is configured to deliver a signal to the drug pump to provide a targeted or systemic therapeutic drug to the organ, the nerve, and/or the second tissue through the lumen running through the first prong.

2. The device of claim 1 , wherein the clip is configured to attach the device to a xiphoid process and/or a sternum of a patient.

3. The device of claim 1 , wherein the clip further comprises:

a bottom portion; and

a spring portion extending between and connecting the top portion to the bottom portion, wherein the spring portion is curved and is configured to act as a spring for the clip to push the top portion of the clip onto the bone, the muscle, and/or the first tissue to which it is anchored.

4. The device of claim 1 , and further comprising:

an electrode positioned on the housing, the clip, and/or the first prong that is in electrical communication with the circuitry and is configured to sense an electrical signal from the organ, the nerve, the first tissue and/or the second tissue and/or is configured to deliver electrical stimulation to the organ, the nerve, the first tissue and/or the second tissue.

5. The device of claim 1 , wherein the therapeutic drug in the drug reservoir is configured to be pumped into the lumen of the first prong using the drug pump.

6. The device of claim 1 , wherein the first prong further comprises:

a base portion on the proximal end of the prong;

a spring portion extending from the base portion;

an arm portion extending from the spring portion; and

a contact portion extending from the arm portion and terminating at the distal end of the prong.

7. The device of claim 6 , wherein the housing further comprises:

a first port on a back side of the housing, wherein the base portion of the prong is positioned in the first port.

8. The device of claim 7 , wherein a second port in the housing fluidly connects to the drug reservoir and is configured to allow the drug reservoir to be replenished.

9. The device of claim 8 , and further comprising:

a second prong with a lumen extending through the second prong and having a proximal end attached to the second port in the housing and the drug reservoir, and a distal end extending away from the housing.

10. The device of claim 9 , wherein the second prong is fluidly connected to the drug reservoir.

11. The device of claim 9 , wherein the second prong is configured to receive replenishment of the drug reservoir through an opening at a distal end of the second prong.

12. A subcutaneously implantable device comprising:

a housing;

a clip attached to a top side of the housing that is configured to anchor the device to a muscle, a bone, and/or a first tissue, wherein the clip includes a top portion that is configured to be positioned on a first side of the muscle, the bone, and/or the first tissue and the housing is configured to be positioned on a second side of the muscle, the bone, and/or the first tissue;

a drug pump and a drug reservoir in the housing, wherein the drug pump is fluidly connected to the drug reservoir;

a first prong with a lumen extending through the first prong and having a proximal end attached to the housing and the drug pump, and a distal end extending away from the housing that is configured to contact an organ, a nerve, and/or a second tissue, wherein the first prong is fluidly connected to the drug pump;

a second prong with a lumen extending through the second prong and having a proximal end attached to the housing and the drug reservoir, and a distal end extending away from the housing, wherein the second prong is fluidly connected to the drug reservoir; and

circuitry in the housing in electrical communication with the drug pump that is configured to deliver a signal to the drug pump to provide a targeted or systemic therapeutic drug to the organ, the nerve, and/or the second tissue through the lumen running through the first prong.

13. The device of claim 12 , wherein the clip is configured to attach the device to a xiphoid process and/or a sternum of a patient.

14. The device of claim 12 , wherein the clip further comprises:

a bottom portion; and

a spring portion extending between and connecting the top portion to the bottom portion, wherein the spring portion is curved and is configured to act as a spring for the clip to push the top portion of the clip onto the bone, the muscle, and/or the first tissue to which it is anchored.

15. The device of claim 12 , further comprising:

an electrode positioned on the housing, the clip, and/or the first prong that is in electrical communication with the circuitry and is configured to sense an electrical signal from the organ, the nerve, the first tissue and/or the second tissue and/or is configured to deliver electrical stimulation to the organ, the nerve, the first tissue and/or the second tissue.

16. The device of claim 12 , wherein the drug in the drug reservoir is configured to be pumped through into the lumen of the first prong using the drug pump.

17. The device of claim 12 , wherein the second prong is configured to receive replenishment of the drug reservoir through an opening at a distal end of the second prong.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2022
From: MANICKA, YATHEENDHAR D.
To: MANICKA INSTITUTE LLC
Reel/Frame 061977/0701 →
Continuity (4)
Continuation 17151522 · Jan 18, 2021
Continuation 16355236 · Mar 15, 2019
Division 16051451 · Jul 31, 2018
Related Publication 20230083368A1 · Mar 16, 2023
References Cited (217)
US 3923060A · Ellinwood, Jr. · 1975 [cited by applicant]
US 4643202A · Roche · 1987 [cited by applicant]
US 4683895A · Pohndorf · 1987 [cited by applicant]
US 6647292B1 · Bardy et al. · 2003 [cited by applicant]
US 6662035B2 · Sochor · 2003 [cited by applicant]
US 6689053B1 · Shaw et al. · 2004 [cited by applicant]
US 7054692B1 · Whitehurst et al. · 2006 [cited by applicant]
US 7239918B2 · Strother et al. · 2007 [cited by applicant]
US 7288096B2 · Chin · 2007 [cited by applicant]
US 7346391B1 · Osorio et al. · 2008 [cited by applicant]
US 7460911B2 · Schulman et al. · 2008 [cited by applicant]
US 7512441B2 · Zhang et al. · 2009 [cited by applicant]
US 7765012B2 · Gerber · 2010 [cited by applicant]
US 7813797B2 · Bardy et al. · 2010 [cited by applicant]
US 7899537B1 · Kroll et al. · 2011 [cited by applicant]
US 8386050B2 · Donoghue et al. · 2013 [cited by applicant]
US 8433412B1 · Westlund et al. · 2013 [cited by applicant]
US 8506474B2 · Chin et al. · 2013 [cited by applicant]
US 8688211B2 · Libbus et al. · 2014 [cited by applicant]
US 8731663B2 · Bianchi et al. · 2014 [cited by applicant]
US 9216285B1 · Boling et al. · 2015 [cited by applicant]
US 9398901B2 · Reiterer et al. · 2016 [cited by applicant]
US 9492669B2 · Demmer et al. · 2016 [cited by applicant]
US 9717898B2 · Thompson-Nauman et al. · 2017 [cited by applicant]
US 9717923B2 · Thompson-Nauman et al. · 2017 [cited by applicant]
US 9884194B2 · Legay et al. · 2018 [cited by applicant]
US 10226618B2 · Reddy et al. · 2019 [cited by applicant]
US 10471251B1 · Manicka · 2019 [cited by applicant]
US 10596383B2 · Ghosh · 2020 [cited by applicant]
US 10639483B2 · Manicka · 2020 [cited by applicant]
US 10716511B2 · Manicka · 2020 [cited by applicant]
US 10765858B2 · Marshall et al. · 2020 [cited by applicant]
US 10981002B2 · Rys · 2021 [cited by applicant]
US 11179571B2 · Manicka · 2021 [cited by applicant]
US 11478650B2 · Manicka · 2022 [cited by applicant]
US 20020095139A1 · Keogh et al. · 2002 [cited by applicant]
US 20020123674A1 · Plicchi et al. · 2002 [cited by applicant]
US 20040115204A1 · Fanger et al. · 2004 [cited by applicant]
US 20040153098A1 · Chin et al. · 2004 [cited by applicant]
US 20040215280A1 · Dublin et al. · 2004 [cited by applicant]
US 20040230273A1 · Cates et al. · 2004 [cited by applicant]
US 20050010259A1 · Gerber · 2005 [cited by applicant]
US 20050080443A1 · Fallin et al. · 2005 [cited by applicant]
US 20050113901A1 · Coe et al. · 2005 [cited by applicant]
US 20050228470A1 · Osypka · 2005 [cited by applicant]
US 20050288563A1 · Feliss et al. · 2005 [cited by applicant]
US 20050288600A1 · Zhang et al. · 2005 [cited by applicant]
US 20060004398A1 · Binder et al. · 2006 [cited by applicant]
US 20060041276A1 · Chan · 2006 [cited by applicant]
US 20060116743A1 · Gibson et al. · 2006 [cited by applicant]
US 20060155180A1 · Brister et al. · 2006 [cited by applicant]
US 20060247748A1 · Wahlstrand et al. · 2006 [cited by applicant]
US 20070004979A1 · Wojciechowicz et al. · 2007 [cited by applicant]
US 20070043394A1 · Zhang et al. · 2007 [cited by applicant]
US 20070123923A1 · Lindstrom · 2007 [cited by examiner]
US 20070255295A1 · Starkebaum et al. · 2007 [cited by applicant]
US 20070265669A1 · Roline et al. · 2007 [cited by applicant]
US 20080132915A1 · Buckman et al. · 2008 [cited by applicant]
US 20080132981A1 · Gerber · 2008 [cited by applicant]
US 20080132982A1 · Gerber · 2008 [cited by applicant]
US 20080243220A1 · Barker · 2008 [cited by applicant]
US 20080298608A1 · Wilcox · 2008 [cited by applicant]
US 20080312712A1 · Penner · 2008 [cited by applicant]
US 20080319503A1 · Honeck et al. · 2008 [cited by applicant]
US 20090082828A1 · Ostroff · 2009 [cited by applicant]
US 20090209986A1 · Stewart et al. · 2009 [cited by applicant]
US 20090299447A1 · Jensen et al. · 2009 [cited by applicant]
US 20100019985A1 · Bashyam et al. · 2010 [cited by applicant]
US 20100022873A1 · Hunter et al. · 2010 [cited by applicant]
US 20100100079A1 · Berkcan et al. · 2010 [cited by applicant]
US 20100114287A1 · Privitera et al. · 2010 [cited by applicant]
US 20100152798A1 · Sanghera et al. · 2010 [cited by applicant]
US 20100198288A1 · Ostroff · 2010 [cited by applicant]
US 20100241181A1 · Savage et al. · 2010 [cited by applicant]
US 20100268041A1 · Kraemer et al. · 2010 [cited by applicant]
US 20100274313A1 · Boling et al. · 2010 [cited by applicant]
US 20110034219A1 · Filson et al. · 2011 [cited by applicant]
US 20110190692A1 · Manda · 2011 [cited by examiner]
US 20110196193A1 · Forsell · 2011 [cited by applicant]
US 20110196483A1 · Forsell · 2011 [cited by applicant]
US 20110196484A1 · Forsell · 2011 [cited by applicant]
US 20110257504A1 · Hendricks et al. · 2011 [cited by applicant]
US 20120029335A1 · Sudam et al. · 2012 [cited by applicant]
US 20120172892A1 · Grubac et al. · 2012 [cited by applicant]
US 20120330123A1 · Doerr · 2012 [cited by applicant]
US 20130073003A1 · Pless et al. · 2013 [cited by applicant]
US 20130085513A1 · North · 2013 [cited by applicant]
US 20130116529A1 · Min et al. · 2013 [cited by applicant]
US 20130138173A1 · Bianchi et al. · 2013 [cited by applicant]
US 20130218195A1 · Kleshinski et al. · 2013 [cited by applicant]
US 20130238067A1 · Baudino · 2013 [cited by applicant]
US 20130310706A1 · Stone et al. · 2013 [cited by applicant]
US 20140074093A9 · Nelson et al. · 2014 [cited by applicant]
US 20140081154A1 · Toth · 2014 [cited by applicant]
US 20140081158A1 · Bodecker et al. · 2014 [cited by applicant]
US 20140088611A1 · Richardson · 2014 [cited by applicant]
US 20140114371A1 · Westlund et al. · 2014 [cited by applicant]
US 20140163579A1 · Kelley et al. · 2014 [cited by applicant]
US 20140309683A1 · Bagwell et al. · 2014 [cited by applicant]
US 20140309699A1 · Houff · 2014 [cited by applicant]
US 20140330248A1 · Thompson-Nauman et al. · 2014 [cited by applicant]
US 20140330287A1 · Thompson-Nauman et al. · 2014 [cited by applicant]
US 20140330325A1 · Thompson-Nauman et al. · 2014 [cited by applicant]
US 20140330326A1 · Thompson-Nauman et al. · 2014 [cited by applicant]
US 20140330327A1 · Thompson-Nauman et al. · 2014 [cited by applicant]
US 20140330329A1 · Thompson-Nauman et al. · 2014 [cited by applicant]
US 20140330331A1 · Thompson-Nauman et al. · 2014 [cited by applicant]
US 20150025591A1 · Sunagawa et al. · 2015 [cited by applicant]
US 20150057563A1 · Kowalski et al. · 2015 [cited by applicant]
US 20150142070A1 · Sambelashvili · 2015 [cited by applicant]
US 20150151026A1 · Gibson · 2015 [cited by applicant]
US 20150257755A1 · North · 2015 [cited by applicant]
US 20150305639A1 · Greenhut et al. · 2015 [cited by applicant]
US 20150306377A1 · Brantigan · 2015 [cited by applicant]
US 20150321016A1 · O'Brien et al. · 2015 [cited by applicant]
US 20150342627A1 · Thompson-Nauman et al. · 2015 [cited by applicant]
US 20150343176A1 · Asleson et al. · 2015 [cited by applicant]
US 20150343197A1 · Gardeski et al. · 2015 [cited by applicant]
US 20150359513A1 · Caluser · 2015 [cited by applicant]
US 20150366556A1 · Khairkhahan et al. · 2015 [cited by applicant]
US 20160067478A1 · Mcgeehan et al. · 2016 [cited by applicant]
US 20160067479A1 · Marcovecchio et al. · 2016 [cited by applicant]
US 20160067480A1 · Sanghera et al. · 2016 [cited by applicant]
US 20160067488A1 · Sanghera et al. · 2016 [cited by applicant]
US 20160129263A1 · Demmer et al. · 2016 [cited by applicant]
US 20160144192A1 · Sanghera et al. · 2016 [cited by applicant]
US 20160158567A1 · Marshall et al. · 2016 [cited by applicant]
US 20160175580A1 · Marshall et al. · 2016 [cited by applicant]
US 20170020551A1 · Reddy et al. · 2017 [cited by applicant]
US 20170021159A1 · Reddy et al. · 2017 [cited by applicant]
US 20170043173A1 · Sharma et al. · 2017 [cited by applicant]
US 20170164939A1 · Ryshkus et al. · 2017 [cited by applicant]
US 20170224995A1 · Sanghera et al. · 2017 [cited by applicant]
US 20170304019A1 · Sanghera · 2017 [cited by examiner]
US 20170304634A1 · Sanghera et al. · 2017 [cited by applicant]
US 20170319863A1 · Thompson-Nauman et al. · 2017 [cited by applicant]
US 20180021572A1 · Mcgeehan et al. · 2018 [cited by applicant]
US 20180036547A1 · Reddy · 2018 [cited by applicant]
US 20180050199A1 · Sanghera et al. · 2018 [cited by applicant]
US 20180085593A1 · Fayram et al. · 2018 [cited by applicant]
US 20180117307A1 · Whitman et al. · 2018 [cited by applicant]
US 20180133494A1 · Reddy · 2018 [cited by applicant]
US 20180193060A1 · Reddy et al. · 2018 [cited by applicant]
US 20180235353A1 · Chen et al. · 2018 [cited by applicant]
US 20180243570A1 · Malinowski et al. · 2018 [cited by applicant]
US 20180272122A1 · Rys · 2018 [cited by applicant]
US 20190254771A1 · Swift et al. · 2019 [cited by applicant]
US 20190321624A1 · De Kock et al. · 2019 [cited by applicant]
US 20200038649A1 · Manicka · 2020 [cited by applicant]
US 20200078584A1 · Manicka · 2020 [cited by applicant]
US 20200147403A1 · Manicka · 2020 [cited by applicant]
US 20200197205A1 · Gage et al. · 2020 [cited by applicant]
US 20200261735A1 · Manicka · 2020 [cited by applicant]
US 20210038276A1 · Schwagli et al. · 2021 [cited by applicant]
US 20210069491A1 · Grubac et al. · 2021 [cited by applicant]
US 20210121684A1 · Manicka · 2021 [cited by applicant]
US 20210146122A1 · Manicka · 2021 [cited by applicant]
CA 2592940A1 · 2008 [cited by applicant]
CN 101125226A · 2008 [cited by applicant]
CN 101610722A · 2009 [cited by applicant]
CN 102209492A · 2011 [cited by applicant]
CN 104470580A · 2015 [cited by applicant]
CN 104797291A · 2015 [cited by applicant]
CN 105078522A · 2015 [cited by applicant]
CN 105102060A · 2015 [cited by applicant]
CN 105377364A · 2016 [cited by applicant]
CN 106362288A · 2017 [cited by applicant]
CN 107233665A · 2017 [cited by applicant]
CN 107847751A · 2018 [cited by applicant]
CN 207654280U · 2018 [cited by applicant]
EP 2281600A1 · 2011 [cited by applicant]
JP 2010502274A · 2010 [cited by applicant]
JP 2012509155A · 2012 [cited by applicant]
JP 2014054549A · 2014 [cited by applicant]
JP 2016517772A · 2016 [cited by applicant]
WO 02054937A2 · 2002 [cited by applicant]
WO 02087688A1 · 2002 [cited by applicant]
WO 2004028348A2 · 2004 [cited by applicant]
WO 2010132254A1 · 2010 [cited by applicant]
WO 2018009913A1 · 2018 [cited by applicant]
WO 2018104476A1 · 2018 [cited by applicant]
WO 20190484182A1 · 2019 [cited by applicant]
WO 2020027888A1 · 2020 [cited by applicant]
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee for PCT Application No. PCT/US2019/028373, dated Jun. 6, 2019, 2 pages. [cited by applicant]
International Search Report and Written Opinion for PCT/US2019/028373, dated Aug. 19, 2019, 15 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2020/059732 mailed Feb. 4, 2021, 10 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2020/059733, dated Feb. 5, 2021, 7 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2021/029151, dated Aug. 17, 2021, 8 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US21/60627, dated Feb. 7, 2022, 12 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US21/60621, dated Feb. 8, 2022, 12 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US21/60625, dated Feb. 18, 2022, 20 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US21/60623, dated Feb. 22, 2022, 7 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2022/011029, dated Mar. 24, 2022, 11 pages. [cited by applicant]
Extended European Search Report for European Patent Application No. 19843134.8, dated Apr. 25, 2022, 6 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2022/026160, dated Jul. 8, 2022, 12 pages. [cited by applicant]
Indian First Examination Report for Indian Patent Application No. 202117003908, dated Mar. 3, 2023, 7 pages. [cited by applicant]
First Review of the Opinion Circular for Chinese Application No. 2019800003911.0, dated Feb. 16, 2023, 26 pages. [cited by applicant]
First Review of the Opinion Circular for Chinese Application No. 202011196767.8, dated Mar. 11, 2023, 17 pages. [cited by applicant]
First Review of the Opinion Circular for Chinese Application No. 202011192123.1, dated Mar. 9, 2023, 17 pages. [cited by applicant]
First Review of the Opinion Circular for Chinese Application No. 202011192209.4, dated Mar. 10, 2023, 24 pages. [cited by applicant]
Notice of Reasons for Refusal for Japanese Patent Application No. 2021529225, dated Mar. 15, 2023, 17 pages. [cited by applicant]
Second Chinese Office Action for Chinese Application No. 202011192209.4, dated Aug. 25, 2023, 18 pages. [cited by applicant]
Second Chinese Office Action for Chinese Application No. 201980003911.0, dated Oct. 23, 2023, 17 pages. [cited by applicant]
Extended European Search Report for European Patent Application No. 20887687.0, dated Nov. 15, 2023, 6 pages. [cited by applicant]
Extended European Search Report for European Patent Application No. 20887104.6, dated Nov. 15, 2023, 5 pages. [cited by applicant]
Chinese Office Action for Chinese Application No. 202011192192.2, dated Feb. 2, 2024, 24 pages. [cited by applicant]
Notice of Decision of Refusal for Japanese Patent Application No. 2021-529225, dated Jan. 10, 2024, 11 pages. [cited by applicant]
Notification of Registration Procedures for Chinese Application No. 202011192209.4, dated Jan. 24, 2024, 11 pages. [cited by applicant]
Notification of Registration Procedures for Chinese Application No. 201980003911.0, dated Jan. 18, 2024, 9 pages. [cited by applicant]
First Chinese Office Action for Chinese Application No. 202011196782.2, dated Feb. 22, 2024, 21 pages. [cited by applicant]
First Chinese Office Action for Chinese Patent Application No. 202011192203.7, dated Feb. 22, 2024, 17 pages. [cited by applicant]
First Chinese Office Action for Chinese Patent Application No. 202080084846.1, dated May 10, 2024, 37 pages. [cited by applicant]
Australian Examination Report for Australian Patent Application No. 2019315780, dated May 21, 2024, 4 pages. [cited by applicant]
Japanese Office Action for Japanese Application No. 2022-526731, dated Jul. 24, 2024, 18 pages. [cited by applicant]
Japanese Office Action for Japanese Patent Application No. 2022-526733, dated Jul. 24, 2024, 30 pages. [cited by applicant]
Extended European Search Report for European Patent Application No. 21867287.1, dated Aug. 6, 2024, 8 pages. [cited by applicant]
Extended European Search Report for European Patent Application No. 21899050.5, dated Sep. 13, 2024, 7 pages. [cited by applicant]